跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ambrolyte - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ambrolyte
Approved
STANDARD
Ambrolyte
Globela Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b78717306325003b
Company
Globela Pharma Private Limited
Type
Standard
Approval Details
Approval Id
b78717306325003b
Drug Approval Philippines Name
Ambrolyte
Product Name
Ambrolyte
Registration Number
DRP-13658
Brand Name
Ambrolyte
Generic Name
Ambroxol Hydrochloride
Dosage Form
Tablet
Dosage Strength
30mg
Manufacturer
Globela Pharma Private Limited
Trader
India
Distributor
AMB HK Enterprises Inc.
Issuance Date
29 March 2023
Expiry Date
29 March 2028
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b78717306325003b
Type
Standard
Back to Philippines FDA Approvals